PTGS2 and obesity disorder: In a recent study, fucoxanthin, at a dose of 0.6% during four weeks, significantly inhibited obesity by the decrease of inflammatory markers production such as TNF-α and cyclo-oxygenase-2 (COX-2) in HF-fed mice [70].